Pharmaceutical compositions

Details Pharmaceutical compositions Pharmaceutical compositions

1991-10-01

1993-07-13

Griffin, Ronald W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514348, 424 10, 424646, 546 2, 546 6, 546296, C07D21369, A61K 31555

Patent

active

RE0343137

ABSTRACT:
Compounds which are a 1-hydroxypyrid-2-one in which one or more of the hydrogen atoms attached to ring carbon atoms are replaced by a substituent selected from aliphatic acyl, aliphatic amide, aliphatic amine, carboxy, cyano, aliphatic ester, halogen, hydroxy and sulpho groups, alkoxy groups and alkoxy groups substituted by an alkoxy, aliphatic amide, aliphatic amine, aliphatic ester, halogen or hydroxy group, aliphatic hydrocarbon groups and aliphatic hydrocarbon groups substituted by an alkoxy, aliphatic ester, halogen or hydroxy group, but excluding compounds in which said replacement of hydrogen atoms in the compound is effected only by substituents selected from aliphatic hydrocarbon groups, halogen groups and aliphatic hydrocarbon groups substituted by a halogen group, or a salt thereof containing a physiolgically acceptable ion or ions, are of value in the treatment of patients having a toxic concentration of a metal, particularly iron, in the body whilst the iron complexes of such compounds are of value in the treatment of iron deficiency anaemia.

REFERENCES:
patent: 2429096 (1947-10-01), Ladd et al.
patent: 2686786 (1954-08-01), Shaw et al.
patent: 2742476 (1956-04-01), Bernstein et al.
patent: 2748142 (1956-05-01), Clauson-Kaas et al.
patent: 3269904 (1966-08-01), Bernstein et al.
patent: 3705943 (1972-12-01), Kaufman
patent: 3810752 (1974-05-01), Wilcox
patent: 3864334 (1975-02-01), Pallos
patent: 3928616 (1975-12-01), Pallos
patent: 3968118 (1976-07-01), Lohaus et al.
patent: 4063927 (1977-12-01), Otten et al.
patent: 4181654 (1980-01-01), Weitl et al.
patent: 4293542 (1981-10-01), Lang et al.
patent: 4309305 (1982-01-01), Weitl et al.
patent: 4358455 (1982-11-01), Atkinson et al.
patent: 4396766 (1983-08-01), Farmer, Jr. et al.
patent: 4397867 (1983-08-01), Blake
patent: 4419365 (1983-12-01), McLachlan
patent: 4442305 (1984-04-01), Weitl et al.
patent: 4530963 (1985-07-01), DeVoe et al.
patent: 4543213 (1985-09-01), Weitl et al.
patent: 4698431 (1987-10-01), Raymond et al.
Chemical Abstracts, 1968, vol. 69, No. 35956t (Japan 67-23351), Aug. 26, 1968.
Chemical Abstracts, 1968, vol. 69, No. 35967x (Japan 67-23194), Aug. 26, 1968.
Chemical Abstracts, 1968, vol. 69, No. 35968y (Japan 67-23196), Aug. 26, 1968.
Chemical Abstracts, 1970, vol. 72, No. 12596y (Japan 69-25582), Jan. 19, 1970.
Chemical Abstracts, 1970, vol. 72, No. 132534y (Japan 70-06268), Jan. 26, 1970.
Chemical Abstracts, 1970, vol. 72, No. 132537b (Japan 70-06267), Jan. 26, 1970.
Mizukami et al. and Nishimura et al, Annual Reports of the Shionogi Research Laboratories, 1966, vol. 16, pp. 29 to 36 and 37 to 40.
Shaw et al, Journal of the American Chemical Society, 1949, vol. 71, pp. 67 to 70 and 70 to 73.
Landers et al, Inorganica Chimica Acta, 1981, vol. 51, pp. 109 to 115 .
Hubbard et al, Inorganic Nuclear Chemical Letters, 1979, vol. 15, pp. 255 to 258.
Pitt et al, Development of Iron Chelators for Clinical Use, Anderson and Hiller (Editors), 1975, p. 137.
Chemical Abstracts, 1983, 100 (18), no. 144833e.
Itoh et al, "The Journal of Antibiotics", vol. XXXII, no. 11, pp. 1089-1095 (Nov. 1979).
Barker et al, Chemical Abstracts, vol. 92, No. 21, May 26, 1980, p. 476, Abstract No. 179021g, the Journal of Antibiotics, vol. 32, No. 11, 1979.
McInnes et al, Journal of the Chemical Society, Chemical Communication, 1974, No. 8 281-282.
Neilands, Science, 1967, 156, 1443-1447.
Dittmar et al. 1974, 17, 753-756.
Durbin, P. W. et al, "Kinetics of Plutonium Deposition in the Mouse," Ann. Rpt. 1983-1984, Biology and Medicine Div, Lawrence Berkeley Lab. Apr. 1985 pp. 56-59.
Durbin, P. W. et al, "New Sequestering Agents for the Actinides . . ," Ann Rpt. 1983-1984, Biology and Medicine Div, Lawrence Berkeley Lab Apr. 1985 pp. 59-64.
Raymond, K. N., "Specific Sequesting Agents for Iron and Actinides," in Environmental Inorganic Chemistry pp. 331-347.
Riley, P. E. et al, "Specific Sequestering Agents for the Actinides. 9. Synthesis of Metal Complexes of 1-Hydroxy-2-Pyridinone . . . ," Inorganic Chem. 22 (1983), pp. 3940-3944.
Scarrow, R. C. et al, "Ferric Ion Sequestering Agents . . . ," Inorganic Chemistry 24 (1985), pp. 954-967.
Scarrow et al., CA 102:124493g, No. 14 Apr. 8, 1985.
Raymond et al, CA 103:192908s No. 23 Dec. 9, 1985.
Chemical Abstracts, vol. 93, no. 13, Sep. 29, 1980 p. 504, col. 2, Abstract No 130476r Itoh et al.
Chemical Abstracts, vol. 64, No. 3, Jan. 31, 1966, col. 3504c Hamamoto et al.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2303784